CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in NKTX — Nkarta, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in NKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$370,659
+$94,302 QoQ
Shares Held
130,975
0.0% QoQ
Ownership
0.183%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 136 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. NKTX ranks #269 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in NKTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $370,659 | 130,975 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $276,357 | 130,975 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $238,973 | 129,175 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $267,392 | 129,175 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $268,548 | 161,776 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $271,493 | 147,551 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $311,282 | 125,013 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $656,900 | 145,332 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $858,912 | 145,332 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $966,716 | 89,428 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $456,119 | 69,109 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $96,061 | 69,109 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $531,813 | 242,837 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $853,171 | 240,330 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,513,696 | 252,704 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,264,785 | 248,084 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,582,986 | 209,658 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,079,973 | 94,901 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,553,235 | 101,188 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,727,410 | 98,073 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,410,319 | 107,615 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,918,291 | 119,097 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,613,680 | 107,592 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,193,574 | 106,240 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||